| RHT Stock | | | CAD 0.22 0.00 0.00% |
Reliq Health financial indicator trend analysis is much more than just breaking down Reliq Health Technologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Reliq Health Technologies is a good investment. Please check the relationship between Reliq Health Research Development and its Ebit accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Reliq Health Technologies Research Development account and
Ebit. At this time, the significance of the direction appears to have pay attention.
The correlation between Reliq Health's Research Development and Ebit is -0.79. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Ebit in the same time period over historical financial statements of Reliq Health Technologies, assuming nothing else is changed. The correlation between historical values of Reliq Health's Research Development and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Reliq Health Technologies are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Research Development i.e., Reliq Health's Research Development and Ebit go up and down completely randomly.
Correlation Coefficient | -0.79 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Most indicators from Reliq Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Reliq Health Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
At this time, Reliq Health's
Selling General Administrative is fairly stable compared to the past year.
Enterprise Value Over EBITDA is likely to climb to 16.73 in 2024, whereas
Sales General And Administrative To Revenue is likely to drop 1.28 in 2024.
| 2020 | 2021 | 2023 | 2024 (projected) |
Cost Of Revenue | 604.2K | 3.3M | 3.7M | 3.9M | Research Development | 1.7M | 2.2M | 2.6M | 1.7M |
When running Reliq Health's price analysis, check to
measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to
predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.